AMGEN INC (AMGN)
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
Address
ONE AMGEN CENTER DRIVE
THOUSAND OAKS, CA 91320
Founded
1980
Number of Employees
26,700
Website
http://www.amgen.com
Buyback
Buyback Data | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
---|---|---|---|---|---|---|---|---|---|---|---|---|
$ Amount Purchased ($ in 000s ) |
$36,275 | $1,149,292 | $2,336,644 | $3,126,001 | - | $7,640,455 | $3,497,454 | $4,987,198 | - | - | - | $3,253,331 |
Average Price | $162.67 | $155.16 | $155.80 | $168.71 | - | $189.85 | $230.24 | $229.50 | - | - | - | $192.47 |
# Shares Purchased | 223,000 | 7,407,115 | 14,997,559 | 18,528,595 | - | 40,244,414 | 15,190,194 | 21,730,283 | - | - | - | 16,903,023 |
Buyback Performance | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Return to Date | 104.1% | 114.0% | 113.1% | 96.8% | - | 74.9% | 44.2% | 44.7% | - | - | - | 72.5% |
S&P 500 Return to Date | 181.9% | 173.0% | 168.6% | 129.7% | - | 93.1% | 74.8% | 31.7% | - | - | - | 121.8% |
Excess Total Return | -77.8% | -59.0% | -55.5% | -32.9% | - | -18.2% | -30.6% | 13.0% | - | - | - | -49.3% |
Quartile Rank |
|
|
|
|
|
|
|
|
|
|
|
|
Percentile Rank | 59% | 62% | 63% | 67% | - | 69% | 53% | 76% | - | - | - | 79% |
Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)